|
|
|
|
|
Current
Neuro-Oncology
|
|
|
|
Volume
26 Number 30
31 December 2024
|
|
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
26, Year 2024 >
Number
30, 31 December
|
|
|
|
|
|
Matsunaga S, Kimura Y, Akiyama Y, Yamamoto
M, Mikuni N.
Congenital
extraventricular neurocytoma with atypical features in a 3-day-old
neonate.
Childs
Nerv Syst. 2024 Dec 21;41(1):64.
doi:
10.1007/s00381-024-06725-w. PMID:
39708128. Case report˰
ˍ
|
|
|
|
*Eun J, Um YH, Han K, Joo WI, Yang SH.
The
impact of depression on risk of malignant glioma: A nationwide
cohort study.
J
Psychosom Res. 2024 Dec 22;189:111982. doi:
10.1016/j.jpsychores.2024.111982. PMID:
39729890. Observational study. ˍ
|
|
|
|
Yamaguchi J, Ohka F, Motomura K, Ishizaki T, Nakahara N, Fujitani
S, Nagatani T, Ohno M, Ando M, Kuwatsuka Y, Nishida K, Saito R.
A
multi-center, open-label, randomized clinical trial evaluating the
preventive effect of perampanel on craniotomy-induced
epileptogenesis in seizure-naive patients
with supratentorial brain tumors: study protocol for a GRAMPAS
trial.
Trials.
2024 Dec 24;25(1):849. doi:
10.1186/s13063-024-08693-7. PMID:
39716271. Interventional study protocol. ˍ
|
|
|
|
Thavaneswaran S, Sim HW, Grady J, Espinoza D, Huang ML, Lin F,
McGrath M, Desai J, Charakidis M, Brown M, Kansara M, Simes J,
Thomas D.
A phase II trial of
larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA
overexpression identified by comprehensive genomic profiling.
Oncologist.
2024 Dec 25:oyae339. doi:
10.1093/oncolo/oyae339. PMID:
39720993. Interventional study. ˍ
|
|
|
|
Aziz N, Waqar U, Bukhari MM, Uzair M, Ahmed S, Naz H, Shamim MS.
Blood transfusions in craniotomy for
tumor resection: Incidence, risk factors, and outcomes.
J
Clin Neurosci. 2024 Dec 26;132:111009. doi:
10.1016/j.jocn.2024.111009. PMID:
39732040. Observational study˰
ˍ
|
|
|
|
Gao K, Zhou T, Yin Y, Sun X, Jiang H, Li T.
Atorvastatin
inhibits glioma glycolysis and immune escape by modulating the
miR-125a-5p/TXLNA axis.
Hereditas.
2024 Dec 26;161(1):54. doi:
10.1186/s41065-024-00349-5. PMID:
39726023. Laboratory investigation. ˍ
|
|
|
|
Gould A, Luan Y, Hou Y, Korobova FV, Chen L, Arrieta VA, Amidei C,
Ward R, Gomez C, Castro B, Habashy K, Zhang D, Youngblood M,
Dmello C, Bebawy J, Bouchoux G, Stupp R, Canney M, Yue F,
Iruela-Arispe ML, Sonabend AM.
Endothelial
Response to Blood-Brain Barrier Disruption in the Human Brain.
JCI
Insight. 2024 Dec 26:e187328. doi:
10.1172/jci.insight.187328. PMID:
39724015. Interventional study. ˍ
|
|
|
|
Nyabuto E, Fenstermaker RA, Qiu J.
Secondary
IDH-mutant gliosarcoma in a patient with prior IDH-mutant grade 2
astrocytoma.
J
Neuropathol Exp Neurol. 2024 Dec 26:nlae131. doi:
10.1093/jnen/nlae131. PMID:
39724916. Case report˰
ˍ
|
|
|
|
Yang L, Xie X, Zhang J, Luo C, Bu L, Wu S, Deng W, Yao Y, Zhang X,
Chen H.
Non-enhancing margin and pial
invasion in MRI can predict IDH status in glioma patients.
World
Neurosurg. 2024 Dec 26:123624? doi: 10.1016/j.wneu.2024.123624?
PMID:
39732457. Observational study˰
ˍ
|
|
|
|
Pasquini L, Napolitano A, Spitoni L, Schmid M, Dellepiane F,
Jenabi M, Peck KK, Holodny AI.
Cognitive
Control Network and Language Reorganization in Patients with Brain
Tumors.
AJNR
Am J Neuroradiol. 2024 Dec 27:ajnr.A8638. doi:
10.3174/ajnr.A8638. PMID:
39730156. Observational study˰
ˍ
|
|
|
|
Grin K, Azizi A, Haberler C,
Peyrl A, Kasprian G, Czech T, Rössler K, Gojo J, Dorfer C.
Cerebellar
pilocytic astrocytoma: predictors of recurrence based on MRI
morphology-a single-centre experience.
Childs
Nerv Syst.
2024 Dec 28;41(1):73. doi:
10.1007/s00381-024-06733-w. PMID:
39733051. Observational study. ˍ
|
|
|
|
Kaushal-Deep SM, Bhat AR, Fayaz M, Scalia G, Robbani I, Wani MA,
Lodhi M, Chaurasia B.
Intraoperative
variations in intra-axial brain tumor size after craniotomy: a
prospective study with histopathological and tumor tissue
composition correlation, introducing concepts of tumor expansion
and tumor surfacing.
Neurosurg
Rev. 2024 Dec 28;48(1):9. doi:
10.1007/s10143-024-03157-7. PMID:
39730869. Observational study˰
ˍ
|
|
|
|
Lesueur P, Clarisse B, Lequesne J, Licaj I, Feuvret L, Stefan D,
Ricard D, Noel G, Balosso J, Lange M, Capel A, Durand-Zaleski I,
Castera M, Legrand B, Goliot N, Hedou C, Grellard JM, Valable S.
Proton therapy versus conventional
radiotherapy for the treatment of cavernous sinus benign
meningioma, a randomized controlled phase III study protocol
(COG-PROTON-01).
BMC
Cancer. 2024 Dec 30;24(1):1594. doi:
10.1186/s12885-024-13353-9. PMID:
39736544. Interventional study protocol. ˍ
|
|
|
|
McFaline-Figueroa JR, Sun L, Youssef GC, Huang R, Li G, Kim J, Lee
EQ, Nayak L, Chukwueke U, Beroukhim R, Batchelor TT, Chiocca EA,
Everson RG, Doherty L, Stefanik J, Partridge K, Spearman A, Myers
A, Westergaard C, Russ A, Lavallee M, Smokovich A, LaForest-Roys
C, Garcia Fox R, McCluskey C, Bi WL, Arnaout O, Peruzzi P,
Cosgrove GR, Ligon KL, Arrillaga-Romany I, Clarke JL, Reardon DA,
Cloughesy TF, Prins RM, Wen PY.
Neoadjuvant
anti-PD1 immunotherapy for surgically accessible recurrent
glioblastoma: clinical and molecular outcomes of a stage 2
single-arm expansion cohort.
Nat
Commun. 2024 Dec 30;15(1):10757. doi:
10.1038/s41467-024-54326-7. PMID:
39737895. Interventional study. ˍ
|
|
|
|
*Panotopoulos C, Athanasiou G, Stavropoulos S, Boutos N, Rao S,
Panayotou G, Venkataramana NK, Ronquist G.
Elimination
of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two
Patient Cases.
Anticancer
Res. 2024 Dec 30;45(1):201-207. doi:
10.21873/anticanres.17405. PMID:
39740841. Case report˰
ˍ
|
|
|
|
Su Y, Wang J, Guo J, Liu X, Yang X, Cheng R, Wang C, Xu C, He Y,
Ji H.
Bi-exponential
diffusion-weighted imaging for differentiating high-grade gliomas
from solitary brain metastases: a VOI-based histogram analysis.
Sci
Rep. 2024 Dec 30;14(1):31909. doi:
10.1038/s41598-024-83452-x. PMID:
39738411. Observational study. ˍ
|
|
|
|
Wang F, Dong J, Xu Y, Jin J, Xu Y, Yan X, Liu Z, Zhao H, Zhang J,
Wang N, Hu X, Gao X, Xu L, Yang C, Ma S, Du J, Hu Y, Ji H, Hu S.
Turning attention to tumor-host
interface and focus on the peritumoral heterogeneity of
glioblastoma.
Nat
Commun. 2024 Dec 30;15(1):10885. doi:
10.1038/s41467-024-55243-5. PMID:
39738017. Laboratory investigation. ˍ
|
|
|
|
Chen L, Wu M, Li Y, Tang L, Tang C, Huang L, Li T, Zhu L.
Assessment of MGMT and TERT Subtypes
and Prognosis of Glioblastoma by Whole Tumor Apparent Diffusion
Coefficient Histogram Analysis.
Brain
Behav. 2024 Dec 31;15(1):e70175. doi:
10.1002/brb3.70175. PMID:
39739534. Observational study. ˍ
|
|
|
|
Chen Y, Yu W, Huang Y, Jiang Z, Deng J, Qi Y.
Causal
Associations between Sleep Traits, Sleep Disorders, and
Glioblastoma: A Two-Sample Bidirectional Mendelian Randomization
Study.
J
Neurophysiol. 2024 Dec 31. doi:
10.1152/jn.00338.2024. PMID:
39740798. Observational study˰
ˍ
|
|
|
|
Fotakopoulos G, Georgakopoulou VE, Spandidos DA, Angelopoulou E,
Menis AA, Trakas N, Alexiou G, Voulgaris S.
Prognostic
factors for first recurrence following meningioma surgery.
Med
Int (Lond). 2024 Dec 31;5(2):14. doi:
10.3892/mi.2024.213. PMID:
39790708. Observational study. ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|